WallStreetZenWallStreetZen

NASDAQ: PPBT
Purple Biotech Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PPBT

Based on 1 analyst offering 12 month price targets for Purple Biotech Ltd

Min Forecast
$33.00+1,061.97%
Avg Forecast
$33.00+1,061.97%
Max Forecast
$33.00+1,061.97%

Should I buy or sell PPBT stock?

Based on 1 analyst offering ratings for Purple Biotech Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PPBT stock forecasts and price targets.

PPBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-15

1 of 1

Forecast return on equity

Is PPBT forecast to generate an efficient return?

Company
-2,455.02%
Industry
153.19%
Market
81.87%
PPBT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PPBT forecast to generate an efficient return on assets?

Company
-2,178.09%
Industry
36.07%
PPBT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PPBT earnings per share forecast

What is PPBT's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.65
Avg 2 year Forecast
-$1.69
Avg 3 year Forecast
-$1.60

PPBT revenue forecast

What is PPBT's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$6.5M
Avg 2 year Forecast
$33.0M
Avg 3 year Forecast
$65.7M

PPBT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PPBT$2.84$33.00+1,061.97%Buy
CYBN$7.29$86.00+1,079.70%Strong Buy
ACIU$1.48$16.00+981.08%Buy
TNGX$1.38$9.67+600.51%Strong Buy
FENC$5.21$13.00+149.52%Buy
View Top Biotech Stocks

Purple Biotech Stock Forecast FAQ

Is Purple Biotech Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PPBT) stock is to Buy PPBT stock.

Out of 1 analyst, 0 (0%) are recommending PPBT as a Strong Buy, 1 (100%) are recommending PPBT as a Buy, 0 (0%) are recommending PPBT as a Hold, 0 (0%) are recommending PPBT as a Sell, and 0 (0%) are recommending PPBT as a Strong Sell.

If you're new to stock investing, here's how to buy Purple Biotech stock.

What is PPBT's earnings growth forecast for 2025-2027?

(NASDAQ: PPBT) Purple Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Purple Biotech's earnings in 2025 is $7,240,000.On average, 1 Wall Street analyst forecast PPBT's earnings for 2025 to be -$853,262,383, with the lowest PPBT earnings forecast at -$853,262,383, and the highest PPBT earnings forecast at -$853,262,383. On average, 1 Wall Street analyst forecast PPBT's earnings for 2026 to be -$873,947,532, with the lowest PPBT earnings forecast at -$873,947,532, and the highest PPBT earnings forecast at -$873,947,532.

In 2027, PPBT is forecast to generate -$827,405,947 in earnings, with the lowest earnings forecast at -$827,405,947 and the highest earnings forecast at -$827,405,947.

What is PPBT's revenue growth forecast for 2028-2030?

(NASDAQ: PPBT) Purple Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Purple Biotech's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PPBT's revenue for 2028 to be $3,361,336,661, with the lowest PPBT revenue forecast at $3,361,336,661, and the highest PPBT revenue forecast at $3,361,336,661. On average, 1 Wall Street analysts forecast PPBT's revenue for 2029 to be $17,065,247,661, with the lowest PPBT revenue forecast at $17,065,247,661, and the highest PPBT revenue forecast at $17,065,247,661.

In 2030, PPBT is forecast to generate $33,975,356,707 in revenue, with the lowest revenue forecast at $33,975,356,707 and the highest revenue forecast at $33,975,356,707.

What is PPBT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PPBT) forecast ROA is -2,178.09%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is PPBT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PPBT price target, the average PPBT price target is $33.00, with the highest PPBT stock price forecast at $33.00 and the lowest PPBT stock price forecast at $33.00.

The Wall Street analyst predicted that Purple Biotech's share price could reach $33.00 by Nov 15, 2025. The average Purple Biotech stock price prediction forecasts a potential upside of 1,061.97% from the current PPBT share price of $2.84.

What is PPBT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PPBT) Purple Biotech's current Earnings Per Share (EPS) is -$44.40. On average, analysts forecast that PPBT's EPS will be -$1.65 for 2025, with the lowest EPS forecast at -$1.65, and the highest EPS forecast at -$1.65. On average, analysts forecast that PPBT's EPS will be -$1.69 for 2026, with the lowest EPS forecast at -$1.69, and the highest EPS forecast at -$1.69. In 2027, PPBT's EPS is forecast to hit -$1.60 (min: -$1.60, max: -$1.60).

What is PPBT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PPBT) forecast ROE is -2,455.02%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.